WEHI scientists have uncovered a promising new way to enhance the effectiveness of vaccines by tapping into the potential of a specific type of immune cell, opening the door to long-lasting vaccines ...

A combination shot for flu and COVID-19 using messenger RNA generated antibodies in a study, but U.S. government regulators ...

In this week’s edition of InnovationRx, we look at Aetna’s withdrawal from the ACA exchanges, the potential for digital ...

Moderna’s study, involving 8,000 adults 50 and older, showed the new combo shot generated an immune response against COVID and most strains of flu compared to existing stand-alone shots.

Moderna’s combined Covid and flu shot outperformed the existing standalone vaccines for both viruses, according to the ...

In Minnesota alone, we represent over 5,000 patients living with conditions like cancer, autoimmune disorders and other ...

Researchers aim to develop a universal vaccine platform that could protect against both COVID-19 and influenza without annual ...

A phase I trial was launched in 2019 for a therapeutic mRNA vaccine, which uses messenger RNA to instruct cells to produce tumour-specific proteins that trigger an immune response. The vaccines ...

ATLANTA, GEORGIA / ACCESS Newswire / April 23, 2025 / Black Book Research today announced the release of its comprehensive 2025 Black Book of Vaccine Informatics and Immunization Technology. The study ...

Register and follow to be notified the next time content from Coronavirus Vaccine is published. Link Copied Coronavirus vaccine FAQs including the latest timetable for vaccine rollout and vaccine ...

This flexibility, coupled with a swift and scalable production process, positions mRNA technology as a promising platform for future vaccines targeting infectious diseases, cancers, and more.